Tesamorelin is a stabilized synthetic peptide consisting of the 44-amino acid sequence of human GHRH appended with a trans-3-hexenoic acid group at the N-terminal tyrosine residue. In laboratory assays, researchers evaluate its enhanced enzymatic stability and downstream impact on peripheral lipolytic mechanisms.
